Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
A
|
AGROB Immobilien AG
F:AGR
|
DE |
|
A
|
Aira Factoring PCL
SET:AF
|
TH |
|
G
|
Grupo Ecoener SA
MAD:ENER
|
ES |
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
Proto Labs Inc
NYSE:PRLB
|
US |
|
V2X Inc
NYSE:VVX
|
US |
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
KR |
|
T
|
TCM Corporation PCL
SET:TCMC
|
TH |
|
SNT Dynamics Co Ltd
KRX:003570
|
KR |
|
Trafalgar Property Group PLC
LSE:TRAF
|
UK |
|
Aker ASA
OSE:AKER
|
NO |
|
Envestnet Inc
NYSE:ENV
|
US |
|
C
|
Chagee Holdings Ltd
NASDAQ:CHA
|
CN |
|
Altamir SCA
PAR:LTA
|
FR |
|
I
|
Insight Digital Partners II
NASDAQ:DYOR
|
US |
Bankruptcy Probability
Amphastar Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Amphastar Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
933.5m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Amphastar Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Amphastar Pharmaceuticals Inc has total debt of 608.7m USD. This includes both short-term (0 USD) and long-term (608.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
